Compare · MDLN vs PDEX
MDLN vs PDEX
Side-by-side comparison of Medline Inc. (MDLN) and Pro-Dex Inc. (PDEX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and PDEX operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $46.86B, about 225.0x PDEX ($208.2M).
- MDLN has hit the wire 12 times in the past 4 weeks while PDEX has been quiet.
- MDLN has more recent analyst coverage (25 ratings vs 0 for PDEX).
- Company
- Medline Inc.
- Pro-Dex Inc.
- Price
- -
- -
- Market cap
- $46.86B
- $208.2M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- News (4w)
- 12
- 0
- Recent ratings
- 25
- 0
PDEX
Pro-Dex Inc.
Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and maxocranial facial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.
Latest MDLN
- SEC Form 4 filed by Chief Executive Officer Boyle James M
- SEC Form 4 filed by Chief Operating Officer Miller Stephen L
- Large owner Gic Private Ltd sold $57,280,000 worth of shares (1,600,000 units at $35.80) (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.
- Large owner Gic Private Ltd sold $21,002,305 worth of shares (590,284 units at $35.58) (SEC Form 4)
- Large owner Mozart Holdco, Inc. converted options into 500,000 shares and disposed of 500,000 units of Class B Common Stock, increasing direct ownership by 81,083% to 233,520,656 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.
- Large owner Gic Private Ltd sold $79,971,448 worth of shares (2,248,612 units at $35.56) (SEC Form 4)
- SEC Form SCHEDULE 13G filed by Medline Inc.
- SEC Form 10-Q filed by Medline Inc.
Latest PDEX
- Director Domingo Angelita Rebamontan was granted 19 shares, increasing direct ownership by 0.10% to 18,798 units (SEC Form 4)
- Director Domingo Angelita Rebamontan sold $47,146 worth of shares (998 units at $47.24), decreasing direct ownership by 5% to 18,779 units (SEC Form 4)
- Chief Financial Officer Charlton Alisha was granted 10,800 shares and covered exercise/tax liability with 3,897 shares, increasing direct ownership by 40% to 24,170 units (SEC Form 4) (tax liability)
- Chief Executive Officer Van Kirk Richard Lee Jr was granted 14,800 shares and covered exercise/tax liability with 5,279 shares, increasing direct ownership by 11% to 99,228 units (SEC Form 4) to cover withholding tax
- Director Domingo Angelita Rebamontan was granted 6,800 shares and covered exercise/tax liability with 2,488 shares, increasing direct ownership by 28% to 19,777 units (SEC Form 4) (for withholding tax)
- Pro-Dex Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Chief Executive Officer Van Kirk Richard Lee Jr sold $626,248 worth of shares (10,000 units at $62.62) as part of a pre-agreed trading plan, decreasing direct ownership by 10% to 89,707 units (SEC Form 4)
- Pro-Dex Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SEC Form 10-Q filed by Pro-Dex Inc.
- Pro-Dex, Inc. Announces Fiscal 2026 Third Quarter and Nine Month Results